We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A second government agency, the Biomedical Advanced Research and Development Authority (BARDA), is now scrutinizing contracts awarded to Moderna, examining whether the vaccine maker failed to disclose millions of dollars it got in federally funded awards in several patents and patent applications the firm has filed for its vaccines. Read More
In a Senate hearing yesterday, National Institutes of Health Director Francis Collins applauded AstraZeneca’s decision to halt its phase 3 COVID-19 vaccine trial due to an unexplained illness — and said the incident should reassure the public that companies are not compromising when it comes to the safety of their vaccine candidates. Read More
Reports “are incorrect” that a participant in AstraZeneca’s COVID-19 vaccine trial that was paused Tuesday suffered from transverse myelitis, an AstraZeneca spokesperson told FDAnews Wednesday. Read More
AbbVie has signed a collaboration agreement with Chinese biotech I-Mab to develop and commercialize, lemzoparlimab (TJC4), I-Mab’s monoclonal antibody under development for multiple cancers. Read More
Three House Democrat committee chairs are demanding that HHS Secretary Alex Azar detail how the department is gearing up for COVID-19 vaccine distribution, how it is working to increase public faith in a vaccine and how it will ensure its decisions aren’t influenced by politics. Read More
Sanofi’s chief in France, Olivier Bogillot, announced Tuesday that shots of the company’s COVID-19 vaccine candidate would likely cost below $11.80 (10 Euro) in Europe should it be approved, in the mid-range of prices that drugmakers are disclosing. Read More
President Trump’s efforts to coax a new strategy from industry to lower drug prices by means of a brandished executive order have been met with silence so far, and the administration is running out of time to show some headway on drug pricing before the Nov. 3 presidential election. Read More
AstraZeneca has paused a late-stage trial of its promising COVID-19 vaccine candidate while it evaluates a single UK patient who may have experienced a serious adverse reaction. Read More
After returning from a month-long congressional hiatus, Senate Majority Leader Mitch McConnell (R-Ky) unveiled a proposed coronavirus relief package on Tuesday that includes $31 billion for COVID-19 medical countermeasures. Read More